Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0075
0.0000
(0.00%)
At close: February 27 at 3:00:00 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-1,348.0890
-1,186.0660
-1,787.2280
413.4790
-986.7840
Financing Cash Flow
--
1,386
1,865
-320.5000
985
End Cash Position
47.3910
372.1200
172.1860
94.4140
1.4350
Interest Paid Supplemental Data
--
--
11.1350
30.0270
--
Issuance of Capital Stock
--
1,561
--
--
640
Issuance of Debt
--
225
1,932
200
345
Repayment of Debt
--
-400
-275
-520
--
Free Cash Flow
-1,348.0890
-1,186.0660
-1,787.2280
413.4790
-986.7840
3/31/2021 - 12/3/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIXT Bioxytran, Inc.
0.0763
+7.31%
ENDV Endonovo Therapeutics, Inc.
0.0002
0.00%
OMGAQ
0.0309
-0.38%
PPCB Propanc Biopharma, Inc.
5.75
0.00%
PHGE BiomX Inc.
0.6243
-8.20%
TRVN Trevena, Inc.
1.5600
0.00%
ALZN Alzamend Neuro, Inc.
0.8200
-2.09%
SPRC SciSparc Ltd.
0.3730
-2.61%
PRTA Prothena Corporation plc
15.81
+4.49%
RKV.V Rakovina Therapeutics Inc.
0.1400
-12.50%